Phantom Limb Pain

The short version

●Phantom limb pain is painful sensation experienced in a limb (or other body part) that has been amputated — distinct from non-painful phantom sensations and from residual-limb (stump) pain.
●It is a neuropathic pain driven by peripheral and central changes, including cortical reorganization and NMDA-receptor-mediated central sensitization.
●No single treatment is reliably effective; management combines medications (gabapentinoids, antidepressants, sometimes opioids), mirror therapy, and graded motor imagery.
●Because central sensitization is NMDA-mediated, ketamine (an NMDA antagonist) has been studied: a controlled study found IV ketamine reduced phantom limb pain.¹
●Systematic reviews find the overall evidence for any pharmacologic treatment of phantom limb pain is limited, and ketamine's benefit tends to be short-lived.² ³
●Tovani treats certain chronic pain conditions; phantom limb pain is complex and usually best managed within a multidisciplinary pain or amputation program.

Clinical definition

Phantom limb pain (PLP) is painful sensation perceived as arising from a limb or body part that has been surgically or traumatically amputated. It is distinguished from phantom sensation (non-painful awareness of the missing limb) and from residual-limb or "stump" pain (pain in the remaining tissue). PLP affects a large majority of amputees to some degree and is classified as neuropathic. Its mechanisms span the peripheral nerve (neuroma formation, ectopic firing), spinal cord (central sensitization mediated substantially by NMDA receptors), and brain (maladaptive cortical reorganization of the sensory homunculus). This NMDA-mediated central sensitization is the rationale for trialing NMDA-antagonist drugs such as ketamine.

How it differs from related conditions

vs. Neuropathic pain

Phantom limb pain is a specific neuropathic pain syndrome; the broader neuropathic-pain category shares mechanisms and several treatments.

vs. Complex regional pain syndrome

CRPS is a regional neuropathic pain with autonomic and trophic changes in an intact limb; PLP is in a missing limb, but both involve central sensitization.

vs. Chronic pain

PLP is one form of chronic pain with a distinctive cause (amputation) and a strong central-sensitization component.

First-line treatments

Gabapentinoids & antidepressants

Gabapentin/pregabalin and tricyclic or SNRI antidepressants are commonly used for the neuropathic component, as in other neuropathic pain.

Mirror therapy / graded motor imagery

Visual and motor-imagery techniques that address maladaptive cortical reorganization, with reasonable evidence and low risk.

Residual-limb & prosthetic care

Optimizing the residual limb, prosthetic fit, and addressing neuromas reduces peripheral drivers of pain.

Multidisciplinary pain management

Combining pharmacologic, physical, and psychological approaches within a pain or amputation program tends to work best.

When standard treatments fail

When first-line measures fail, options include trials of NMDA antagonists (ketamine), interventional procedures (nerve blocks, targeted muscle reinnervation surgery for neuromas), and neuromodulation. The evidence for any single approach is limited and individual response varies, so care is typically iterative and best coordinated within a multidisciplinary pain service.

Where ketamine fits

Phantom limb pain involves NMDA-receptor-mediated central sensitization, which is the direct rationale for ketamine: by blocking the NMDA receptor it can reduce the "wind-up" that maintains the pain. A controlled study found intravenous ketamine produced meaningful reduction in phantom limb pain compared with control.¹ However, systematic reviews of phantom limb pain treatments emphasize that the overall evidence base is limited and that ketamine's analgesic effect is typically short-lived, raising practical questions about durable benefit.² ³ It is therefore best viewed as one option within a multidisciplinary plan rather than a standalone cure, and is usually delivered in pain-specialist settings.

Where this fits with Tovani

Tovani treats several chronic pain conditions, but phantom limb pain is a complex, multifactorial syndrome that is usually best managed within a multidisciplinary pain or amputation program where mirror therapy, prosthetic optimization, and interventional options are available alongside any medication. Where ketamine is considered for the neuropathic component, the short duration of its analgesic effect and the need for coordinated care make a specialist pain setting the more appropriate home for most patients.

Check eligibility Find treatment options The science behind ketamine

Frequently asked

Can ketamine help phantom limb pain?

There's a real mechanistic rationale — phantom limb pain involves NMDA-mediated central sensitization, and ketamine blocks the NMDA receptor. A controlled study found IV ketamine reduced the pain. But the effect tends to be short-lived and the overall evidence is limited, so it's one option within a broader plan, not a cure.

What's the best treatment for phantom limb pain?

There isn't a single reliably effective treatment. The strongest combined approach pairs neuropathic-pain medications (gabapentinoids, certain antidepressants) with mirror therapy or graded motor imagery and good residual-limb/prosthetic care, ideally within a multidisciplinary pain program.

Is phantom limb pain the same as stump pain?

No. Phantom limb pain is felt in the missing limb; residual-limb or "stump" pain is in the remaining tissue. They can coexist but have different causes and treatments — stump pain often relates to neuromas or prosthetic fit.

Does Tovani treat phantom limb pain?

We treat several chronic pain conditions, but phantom limb pain is complex and usually best handled by a multidisciplinary pain or amputation program. Because ketamine's pain relief here tends to be short-lived, a specialist pain setting is the more appropriate place for most patients.

References

Eichenberger U et al. 2008, Anesthesia & Analgesia — Controlled study: intravenous ketamine reduced phantom limb pain. (PMID 18349204)
Alviar MJ et al. 2016, Cochrane Database of Systematic Reviews — Systematic review finding limited overall evidence for pharmacologic treatment of phantom limb pain. (PMID 27737513)
Hall N & Eldabe S 2018, British Journal of Pain — Review of pharmacological management of phantom limb pain, including NMDA antagonists. (PMID 30349693)

Last reviewed by Dr. Ben Soffer, DO on June 2, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.